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Abstract
Aims To investigate concordance with medication, as assessed at baseline and at 1- and 2-year follow-up, and to
examine factors associated with non-concordance in a UK-resident South-Asian population.
Methods Data from the UK Asian Diabetes Study were analysed. Concordance with medications was assessed and
recorded at three time points during the study. Multiple logistic regression was used to investigate the factors associated
with non-concordance; the associations of baseline factors with year 1 concordance and baseline plus year 1 factors with
year 2 concordance.
Results Data for 403 patients from seven practices participating in the UK Asian Diabetes Study were analysed. The
numbers of patients who were non-concordant were: 63 (16%) at baseline; 101 (25%) at year 1; and 122 (30%) at year
2. The baseline-measured variables that were significantly associated with year 1 non-concordance included diabetes
duration, history of cardiovascular disease, components of the EuroQol quality of life questionnaire, the EQ-5D score,
and number of medications prescribed. In multivariable analyses, the most important determinant of year 1
non-concordance was baseline non-concordance: odds ratio 13.6 (95% confidence limits 4.7, 39.9). Number of
medications prescribed for blood pressure control was also significant: odds ratio 1.8 (95% confidence limits 1.4, 2.4).
Similar results were observed for year 2 non-concordance.
Conclusions Non-concordance with medications was common and more likely in people prescribed more medications.
The current target-driven management of risk factor levels may lead to increasing numbers and doses of medications.
Considering the high cost of medications and the implications of poor health behaviours on morbidity and mortality,
further investigation of prescribing behaviours and the factors affecting patient concordance are required.
Diabet. Med. 00, 000–000 (2014)
Introduction
Type 2 diabetes is a major public health concern in the UK,
particularly in the South-Asian population [1–3]. Poorer
self-reported health in this minority ethnic group has been
shown to be strongly linked to the use of health services and
also to mortality [4]. Specific diabetes management problems
for minority ethnic populations include cultural and com-
munication difficulties which make appropriate support of
self-care for diabetes (including medication taking) more
difficult [5–11]. These issues were highlighted in a prospec-
tive study in South-Asian people with Type 2 diabetes
which showed that, despite attempts to improve diabetes
knowledge and engagement with healthcare services, more
work needed to be done to discover why self-management
remains poor [12].
A recent report on prescribing for diabetes in England
(2011) found that there had been a marked increase in the
proportion of all prescriptions written for diabetes and that
‘drugs for diabetes’ were associated with the greatest increase
in cost in primary care in England in 2010/2011, now
amounting to 8.4% of total cost of prescribing [13]. This is,
for the most part, a response to the target-driven manage-
ment of diabetes with the continuing ‘payment-for-perfor-
mance’ initiative [14].
Diabetes is a complex chronic condition and people with
Type 2 diabetes are usually prescribed multiple medicines to
improve glycaemic, blood pressure and cholesterol control.Correspondence to: Cathy E. Lloyd. E-mail: Cathy.Lloyd@open.ac.uk
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The effectiveness of this approach has been shown clearly in
a number of studies, including the UK Prospective Diabetes
Study [12]; however polypharmacy is not without its
problems, and there have been several studies which have
shown poor concordance with medication where regimens
are complex or where multiple medications are involved [15–
18]. Other factors associated with non-concordance include
the type of medication prescribed [16], poor understanding
of the benefits of medication, side effects and poor mental
health, particularly where patients report symptoms of
depression [19,20].
To date, there has been little non-concordance research in
minority ethnic groups. Limited evidence suggests that
concordance with medications may be even more problem-
atic because of poor diabetes knowledge and communication
difficulties [16]. Social support has also been recognized as
an important influence on medication-taking [21] as well as
the relationship between doctor and patient; these may be
particularly compromised in people from South-Asian back-
grounds living in the UK.
In the UK Asian Diabetes Study (UKADS), a large 2-year
cluster randomized multiple cardiovascular intervention
trial in the community, there was an improvement in
blood pressure over time, but no differences in cholesterol
or glycaemic control were found [12]. Furthermore, despite
enhanced nurse care, link worker assistance and specialist
nurse input in the intervention arm of the study, the
benefits were limited to small improvements in blood
pressure. Possible reasons for this included the potential
impact of non-concordance with medications. The aims of
the present study were to investigate levels of concordance
with medications and to examine the factors that might be
associated with non-concordance in the UKADS popula-
tion.
Methods
The present study aimed to collate and examine the available
data on medication, taking into account data on attendance
rates and psychological well-being, which had been previ-
ously collected on the participants in the UKADS. Full details
of the UKADS have been published elsewhere [12]. Briefly,
the UKADS comprised a cluster randomized controlled trial
conducted in Coventry and Birmingham, UK, during the
period March 2004 to April 2007. The UKADS was designed
to examine the clinical and cost-effectiveness of a structured,
culturally sensitive, enhanced care package for people with
Type 2 diabetes from South-Asian backgrounds for the
improvement of cardiovascular risk factors and subsequent
cardiovascular outcomes [22]. Participants in the interven-
tion arm of the study were seen approximately every 2
months and met with a practice nurse, supported by an Asian
link worker and a diabetes specialist nurse. Participants in
the control group attended routine 3–6-monthly diabetes
clinics led by a practice nurse. At each UKADS visit
participants were asked to bring all their medicines with
them (in their original containers) as well as any repeat
prescription scripts they had. The nurse researcher recorded
which medications the participants reported taking, how
often they took them and at what level (i.e. number of tablets
taken each time). This information was immediately checked
with their computerized medical records to ascertain whether
the participant’s report of the medications they were taking
corresponded with the information recorded in their notes or
on the medication containers. Any discrepancies were noted
on their medical records and were discussed with the
participant, with recommendations made if any change in
medication-taking was required. Any decisions made were
informed by the most recent blood test results and, where
required, the participant was asked to make an appointment
with their general practitioner.
For the purposes of the present study, concordance with
medications was strictly defined as follows:
 Concordance = where the patient reported taking all their
medication at the level they had been prescribed (as
recorded in their medical records).
 Non-concordance = where the patient reported not taking
one or more medications at the level they had been
prescribed (i.e. any deviation from prescribed regimen).
A random sample of participating general practices from
both the intervention and control arms of the UKADS was
identified and the study case notes for each participant in
those practices were examined for each year of the study. The
data collected included type of general practice (single vs
group), number of follow-up visits attended/not attended per
year of the study, and the number of medications taken for
diabetes, blood pressure, high cholesterol and for other
conditions. In the UKADS, urinary albumin:creatinine ratio
What’s new?
• This study is one of very few to examine the factors
associated with non-concordance with medications in
people with Type 2 diabetes from minority ethnic
backgrounds.
• Our research, in South-Asian people with diabetes,
shows the importance of understanding the range of
factors that might influence concordance with medica-
tions .
• Intensification of treatment may be ineffective where
there is already poor concordance with prescribed
medications, and alternative strategies for improving
self-management need to be identified.
• Given the huge economic cost of polypharmacy, this
issue has important implications for both public health
and clinical practice.
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was estimated. Overt proteinuria was defined as a urinary
albumin:creatinine ratio ≥30.0 mg/mmol for both men and
women and microalbuminuria was defined a a urinary
albumin:creatinine ratio 2.5 to <30.0 mg/mmol for men
and 3.5 to <30.0 mg/mmol for women, with values below
these thresholds indicating normal albuminuria [22]. Infor-
mation on history of previous cardiovascular disease, includ-
ing coronary heart disease, stroke, peripheral vascular
disease and angina was extracted [23]. Participants com-
pleted the EuroQol quality-of life questionnaire, known as
the EQ-5D, as well as the EQ-5D Visual Analogue Scale
(http://www.euroqol.org) at three time points in the study: at
baseline and at 1- and 2-year follow-up. The five items of the
EQ-5D are designed to measure level of perceived health
problems and include mobility, self-care (washing and
dressing), usual activities (work, study, housework, family
or leisure activities), pain or discomfort and anxiety or
depression. Each item is rated separately on a three-point
scale: 1, no problems; 2, moderate/some problems; and 3,
extreme problems. Higher mean EQ-5D index values and
EQ-5D Visual Analogue Scale scores indicate poorer per-
ceived health status. Use of antidepressant medications was
recorded, along with information on diagnosis or treatment
for psychiatric problems. Country of birth and family history
of diabetes were also recorded.
To adjust estimates for deprivation, we used the Index of
Multiple Deprivation 2007 [23], extracting an individual
score using the standard postcode (postal delivery address),
which is a good indicator of individual socio-economic status
[24]. The Index of Multiple Deprivation is based on seven
domains and is available at small area level (Index of
Multiple Deprivation 2007 lower super output level score,
obtained using National Statistics Postcode Directory, via
GeoConvert: http://geoconvert1.ds.man.ac.uk/application/
step1metadata_display.cfm).
Statistical analyses were conducted using SAS. To examine
the association between outcomes (non-concordance) at
follow-up years 1 and 2 and each of the explanatory
variables (measured at baseline or at year 1), frequencies,
proportions and comparisons of mean, chi-squared tests,
Students t-tests and Wilcoxon non-parametric tests were
performed as appropriate.
Stepwise selection logistic regression modelling was con-
ducted to identify statistically significant predictors of
concordance at year 1, using baseline measures, and at year
2, using year 1 measurements. Models were also evaluated
for patients in intervention and control practices separately.
To analyse and evaluate combined variables measured at
baseline and year 1 on final year 2 concordance status,
logistic models were fit using baseline variables and concor-
dance, then changes between baseline and year 1 were added.
Hierarchical logistic regression models using SAS PROC GLIM-
MIX software were also fit. In modelling, to avoid collinearity,
individual components of the EQ-5D score were used, but
overall score and Visual Analogue Scale score were excluded.
Modelling was repeated for the intervention and control
arms separately and for total number of medications
prescribed vs numbers of medications prescribed for indi-
vidual conditions.
In the final models (presented), gender, duration of
diabetes, HbA1c and family history of diabetes, none of
which were included in the automatic selection models
processes, were included as potentially confounding vari-
ables, irrespective of statistical significance. Linear regression
models were used to assess and address issues of collinearity
and the final logistic models selected balanced collinearity
with highest maximum adjusted R2 statistic.
Results
The case notes of 403 participants in the UKADS were
analysed. At baseline assessment, 84% of study participants
were coded as concordant. This proportion fell at each of the
following year time points, but with some crossover from
non-concordant to concordant status (Table 1, Fig. 1).
Study participants comprised 214 women and 189 men,
with a mean age of 55 years and 8 years duration of diabetes.
Significant differences between concordant and non-concor-
dant groups at baseline were observed for age, duration of
diabetes, total cholesterol and numbers of medications, plus
cardiovascular disease history, albuminuria status and miss-
ing follow-up appointments. Significant associations were
observed between baseline measures and year 1 outcome
(concordance status) and between year 1 and year 2
outcomes for a number of other factors, including total
EQ-5D scores and the single-item EQ-5D depression/anxiety
score, activity score, self-care and mobility scores. Taking a
higher number of blood pressure, cholesterol and other
medications were all significantly associated with non-
concordance (Table 2, Table S1).
Results of multiple logistic regression modelling:
Year 1 non-concordance
In forward selection multiple logistic regression modelling
to evaluate baseline predictors of year 1 non-concordance,
Table 1 Concordance status over the study period
Time point
Concordant status, n (%)
Yes No
Baseline 340 (84) 63 (16)
Year 1 follow-up 302 (75) 101 (25)
Year 2 follow-up 281 (70) 122 (30)
Summary, n (%)
Fully concordant (all three time points) 259 (64)
Partially concordant (one or two time
points)
92 (23)
Always non-concordant (no time points) 52 (13)
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five variables were identified: number of blood pressure
medications; number of ‘other’ medications; EQ-5D depres-
sion and anxiety score; attained age; and intervention vs
control status. The addition of concordance status at baseline
into the model identified this as a further factor, with no
previously identified factors removed (Table 3). Repeating
this analysis, with total number of medications replacing the
individual numbers of medications, identified the equivalent
set of predictors: baseline concordance status; total number
of medications prescribed; EQ-5D depression and anxiety
score; intervention vs control status; and age.
Running the same logistic regression in a forward selection
procedure for the patients in the intervention and control
arms separately identified three significant predictor variables
for patients in the intervention arm: baseline concordance;
number of blood pressure medications; plus number of
‘other’ medications, compared with four significant predic-
tors for patients in the control arm: concordance at baseline;
number of blood pressure medications; age; and EQ-5D
score. Potentially confounding baseline factors (duration of
diabetes, family history of diabetes, HbA1c and gender) were
added to produce a final predictive model (Table 3).
Non-concordance at baseline, intervention vs control
practice status, increasing age, severe EQ-5D depression
and anxiety score and higher numbers of medications
prescribed to control blood pressure or for ‘other’ reasons
all increased significantly the odds of non-concordance at
year 1 follow-up (Table 3). Repeating these analyses using
total medications prescribed had no effect on the significance
of predictors in the model; odds ratios for all variables
increased, except for EQ-5D depression and anxiety score,
which decreased.
Year 2 non-concordance
In forward selection multiple logistic regression, using vari-
ables measured at year 1 in a predictive model for year 2
non-concordance, only number of blood pressure control
medications and EQ-5D depression and anxiety score at year
1 were statistically significant (Table 4). Adding year 1
concordance status and re-running the selection process
identified year 1 non-concordance and history of cardiovas-
cular disease only; neither number of blood pressure control
medications nor EQ-5D depression and anxiety score
remained significant (Table 4). Re-running the selection
process for the patients in the intervention and control arms
separately identified non-concordance at year 1 for both arms,
plus age for the patients in the intervention arm and history of
cardiovascular disease for the patients in the control arm.
In the final model, including all variables identified in
selection processes plus potentially confounding variables,
Transitions: Became concordant = 8 (13%) Became non-concordant = 46 (14%)
Transitions: Became concordant = 17 (17%) Became non-concordant = 38 (13%)
Baseline: 
340 (84%) patients 
concordant 
Baseline:
63 (16%) patients not 
concordant
Year 1: 
302 (75%) patients 
concordant (340 - 46 + 8)
Year 1:
101 (25%) patients not 
concordant (63 - 8 + 46)
Year 2: 
281 (70%) patients 
concordant (302 - 38 + 17)
Year 2:
122 (30%) patients 
concordant (101 - 17 + 38)
Always concordant: 
259 (64%) patients 
Part concordant: 
92 (23%) patients  
Never concordant:
52 (13%) patients
FIGURE 1 403 study patients: Baseline, year 1 and year 2 concordance prevalences, with transitions
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Table 2 Association of factors measured at baseline with lack of concordance at year 1
Factor
Concordant at
year 1
Non-concordant
at year 1 Statistical test
Gender, n (%)
Female 163 (76) 51 (24) chi-squared = 0.3677, P = 0.5442
Male 139 (74) 50 (26)
Mean (SD) attained age 53.4 (11.1) 59.3 (11.3) Difference (95% CI):
5.9 (1.3–11.1)
T = 4.58, P < 0.0001
Mean (SD) duration of diabetes, years 7.4 (6.0) 10.3 (8.3) Difference (95% CI):
2.9 (0.8–6.6)
P = 0.0092*
Mean (SD) HbA1c mmol/mol
% †
66 (21)
(8.2 (1.9))
69 (21)
(8.5 (1.9))
Difference % (95% CI):
0.3 (-0.1 to 0.8)
T = 1.41, P = 0.1583
Mean (SD) systolic blood pressure 136.0 (19.0) 144.4 (21.9) Difference (95% CI):
8.4 (3.9–13.2)
P = 0.0003*
Mean (SD) diastolic blood pressure 82.4 (9.9) 84.0 (13.0) Difference (95% CI):
1.6 (-1.2 to 4.3)
P = 0.0980*
Mean (SD) total cholesterol 4.8 (1.1) 4.6 (1.0) Difference (95% CI):
0.2 (-0.0 to 0.5)
T = 1.67, P = 0.0951
Cardiovascular disease history, n (%)
Yes 32 (44) 40 (56) chi-squared = 43.9495, P < 0.0001
No 269 (82) 60 (18)
Albuminuria, n (%)
Normal 216 (76) 69 (24) chi-squared = 8.0908, P = 0.0175
Microalbuminuria 67 (79) 18 (21)
Overt proteinuria 11 (50) 11 (50)
Mean (SD) EQ-5D index 0.6 (0.3) 0.5 (0.4) Difference (95% CI):
0.1 (0.0–0.2)
T = 3.16, P = 0.0017
Mean (SD) EQ-5D Visual Analogue Scale 65.6 (23.0) 57.7 (22.3) Difference (95% CI):
7.9 (2.4 to 13.5)
T = 2.80, P = 0.0054
Family history of diabetes, n (%)
Yes 165 (77) 50 (23) chi-squared = 0.8006, P = 0.3709
No 137 (73) 51 (27)
EQ-5D depression and anxiety, n (%)
None 179 (80) 46 (20) chi-squared = 16.0962, P = 0.0003
Mild/Moderate 83 (75) 28 (25)
Severe 15 (47) 17 (53)
EQ-5D pain, n (%)
None 81 (81) 19 (19) chi-squared = 2.6190, P = 0.2700
Mild/Moderate 139 (72) 53 (28)
Severe 57 (75) 19 (25)
EQ-5D activity, n (%)
None 168 (83) 35 (17) chi-squared = 17.0295, P = 0.0002
Mild/ Moderate 81 (69) 36 (31)
Severe 26 (57) 20 (43)
EQ-5D Self-care, n (%)
None 225 (80) 55 (20) chi-squared = 16.2685, P < 0.0001
Mild/Moderate/Severe 52 (59) 36 (41)
EQ-5D Mobililty, n (%)
None 146 (52) 31 (18) chi-squared = 6.5352, P = 0.0020
Mild/Moderate/Severe 131 (69) 60 (31)
Blood pressure medications, n (%)
0 126 (95) 7 (5) chi-squared = 127.0302, P < 0.0001
1–2 144 (81) 33 (19)
3–4 29 (46) 34 (54)
≥5 3 (10) 27 (90)
Cholesterol medications, n (%)
0 182 (89) 23 (11) chi-squared = 42.5702, P < 0.0001
1–2 120 (61) 78 (39)
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only year 1 non-concordance remained statistically signifi-
cant, increasing the odds of non-concordance at year 2
(Table 4). Substituting total number of medications pre-
scribed rather than numbers prescribed for blood pressure
control increased the estimate and odds ratio for year 1
non-concordance as predictor of year 2 non-concordance
which remained significant: odds ratio 27.7 (95% confidence
limits 11.2, 68.5), P<0.0001. No other variables were
statistically significant.
Using forward selection multiple logistic regression with
baseline-measured variables, non-concordance, EQ-5D self-
care score and number of blood pressure control medications
were all significant predictors for year 2 non-concordance
(Table 5). Repeating this analysis with changes to concor-
dance status at year 1 from baseline and with changes to
numbers of medications prescribed identified the same
predictors, plus change in non-concordance status (Table 5).
Using a mixed-effects hierarchical model, with fixed effect
for baseline concordance and random effect for year 1,
baseline non-concordance, number of baseline blood pres-
sure medications and EQ-5D self-care score remained statis-
tically significant: odds ratio for baseline non-concordance
7.1 (95% confidence limits 2.8, 18.5).
Discussion
Rates of prescribing for diabetes are at an all-time high, but it
is clear from the present research and that of others that
medications are not always taken as recommended [15–18].
Our research shows that, whilst only a small proportion of
patients may be continuously non-concordant, individual
concordance status may change over time, and this has
important implications for practice; for example, in terms of
frequency of follow-up appointments to support appropriate
medication-taking. An awareness of the impact of taking
multiple medications on a daily basis is vital, as is engaging
with patients in an open discussion on the importance of
self-medicating behaviour and supporting individuals to
maximize this aspect of diabetes self-care.
To date, research in South-Asian populations has focused
on perceptions of insulin treatment and has shown that there
may be a reluctance to move from oral anti-diabetic drugs to
insulin therapy [25]. Research in the wider diabetes popu-
lation has mainly considered how particular aspects of
self-management such as diet, physical activity and self-mon-
itoring of blood glucose influence blood glucose control, with
less research on the impact of appropriate medication-taking
and, specifically, the use of oral anti-diabetic drugs. Those
studies that do exist have reported that non-concordance
with oral anti-diabetic drugs leads to more hospitalizations
and higher mortality rates [26]. The present study showed
that, over time, whilst there was some movement from
non-concordant to concordant, the overall trend was
towards more non-concordance. Whether there are specific
benefits for those who are concordant that outweigh any
detriment for those who are not concordant remains
unknown and requires more in-depth investigation. Further-
more, whether or not those who are non-concordant with
their polypharmacy have better or worse outcomes compared
with those who are concordant with a regimen consisting of
fewer drugs remains unknown.
In the present study, there was no difference between
concordant and non-concordant patients at any of the three
time points with respect to Index of Multiple Deprivation
2007 score, which was perhaps unexpected; however, it is
important to note that average Index of Multiple Deprivation
2007 scores for the patients in the present study were
considerably higher than for those in either the Coventry or
Birmingham study groups, suggesting that the patients in the
present study were more deprived overall. There was no
Table 2 (Continued)
Factor
Concordant at
year 1
Non-concordant
at year 1 Statistical test
Diabetes medications, n (%)
0 97 (78) 27 (22) chi-squared = 2.1381, P = 0.3433
1 103 (76) 32 (24)
2–3 102 (71) 42 (29)
Other medications, n (%)
0 171 (84) 33 (16) chi-squared = 21.1970, P < 0.0001
1–2 107 (69) 48 (31)
≥3 24 (55) 20 (45)
Missed follow-up appointments, n (%)
No 281 (76) 90 (24) chi-squared = 2.2677, P = 0.1321
Yes 19 (63) 11 (37)
Missing values: albuminuria, n =11; EQ-5D anxiety, n =35; EQ-5D pain, n =35; EQ-5D activity, n =37; EQ-5D self-care, n =35; EQ-5D
mobility, n =35; cardiovascular disease history, n = 2, missed follow-up appointments, n =2.
*Variances unequal, statistical test was non-parametric Mann–Whitney U-test.
†Diabetes Control and Complications Trial-aligned HbA1c
CI, Confidence Interval.
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significant difference in deprivation score comparing the
included general practices, suggesting there was insufficient
variation in deprivation in our sample to detect concor-
dance-related differences. Investigation of the relationship
between deprivation scores and concordance levels may be a
useful avenue for future enquiry.
Table 3 Logistic regression modelling: factors influencing year 1 non-concordance
Variable Estimate P
Odds ratio
(95% CI)
Forward selection procedure
Non-concordant at baseline vs concordant 2.4265 <0.0001 11.3 (4.1, 31.6)
Number of blood pressure control medications prescribed at
baseline
0.6248 <0.0001 1.9 (1.4, 2.5)
EQ-5D depression/anxiety (vs none)
Mild/moderate 0.2486 0.5302 1.3 (0.6, 2.8)
Severe 2.1561 0.0005 8.6 (2.6, 28.9)
Number of medications for ‘other’ reasons prescribed at baseline 0.3712 0.0060 1.4 (1.1, 1.9)
Intervention vs control 0.9742 0.0089 2.6 (1.3, 5.5)
Attained age (years) 0.0408 0.0192 1.04 (1.01, 1.1)
Final model with confounders
Non-concordant at baseline vs concordant 2.6129 <0.0001 13.6 (4.7, 39.9)
Intervention vs control 1.0576 0.0058 2.9 (1.4, 6.1)
Sex (male vs female) 0.4183 0.3836 1.5 (0.7, 3.2)
Attained age (years) 0.0451 0.0176 1.1 (1.0, 1.1)
Duration of diabetes (years) 0.0203 0.5171 1.0 (0.9, 1.0)
HbA1c (Diabetes Control and Complications Trial-aligned) 0.0994 0.3119 1.1 (0.9, 1.3)
Baseline family history of diabetes (yes vs no) 0.4830 0.2201 0.6 (0.3, 1.3)
EQ-5D depression/anxiety (vs none)
Mild/Moderate 0.2994 0.4721 1.3 (0.6, 3.1)
Severe 2.2303 0.0003 9.3 (2.8, 31.4)
Number of blood pressure control medications prescribed at
baseline
0.6029 <0.0001 1.8 (1.4, 2.4)
Number of medications for ‘other’ reasons prescribed at baseline 0.3895 0.0045 1.5 (1.1, 1.9)
CI, Confidence Interval.
Table 4 Logistic regression modelling: factors measured at year 1 influencing non-concordance at year 2 follow-up
Variable Estimate P
Odds ratio
(95% CI)
Forward selection procedure (two models):
Model 1 - year 1 factors only:
EQ-5D depression/anxiety at year 1
Mild/Moderate vs None 0.6763 0.0360 2.0 (1.0, 3.7)
Severe vs None 1.6036 0.0003 5.0 (2.1, 11.8)
Number of blood pressure control medications prescribed
at year 1
0.7113 < 0.0001 2.0 (1.7, 2.4)
Model 2 - year 1 factors + year 1 concordance:
Non-concordant at year 1 vs concordant 3.5460 < 0.0001 34.7 (16.7, 72.1)
History of cardiovascular disease
Yes vs No 0.9738 0.0206 2.6 (1.2, 6.0)
Final model:
Non-concordant at year 1 vs concordant 3.1543 < 0.0001 23.4 (9.7, 56.5)
Number of blood pressure control medications prescribed
at year 1
0.1309 0.3247 1.1 (0.9, 1.5)
EQ-5D depression/anxiety at year 1
Mild/Moderate vs None 0.2696 0.4969 1.3 (0.6, 2.9)
Severe vs None 0.5935 0.2876 1.8 (0.6, 5.4)
History of cardiovascular disease
Yes vs No 0.7510 0.1177 2.1 (0.8, 5.4)
Attained age (years) 0.0113 0.5021 1.0 (1.0, 1.0)
Duration of diabetes (years) 0.0344 0.1995 1.0 (1.0, 1.1)
HbA1c (Diabetes Control and Complications Trial-aligned) 0.0450 0.6357 1.0 (0.8, 1.2)
Sex (Male vs Female) 0.2194 0.5414 0.8 (0.4, 1.6)
CI, Confidence Interval.
ª 2014 The Authors.
Diabetic Medicine ª 2014 Diabetes UK 7
Research article DIABETICMedicine
In the present study, non-concordance was associated with
taking a greater number of medications (particularly blood
pressure medications), which supports previous research
[18,27] and has important implications for clinical practice.
Previous studies have reported that the polypharmacy
required to achieve good glycaemic control is a significant
barrier to concordance [27].
Knowledge and understanding of medications may be an
important factor influencing concordance [8]. In their study
in individuals with Type 2 diabetes, Dunning et al. [28]
showed that knowledge of medications was poor and 20% of
patients regularly forgot to take the medications, with the
increasing cost of prescribed medications cited as a reason
for deliberately not taking or reducing the dose of medication
taken. Surprisingly, the present study did not find a statis-
tically significant association between socio-economic status
(potentially related to concerns with the financial cost) and
concordance, something that we are not able to explain.
Other studies have shown the importance of beliefs about
medications with regard to medication-taking [7,10,29].
Future research needs to examine these issues in other
minority groups [30].
Patients may take their medications initially, but if the
importance of continuing this behaviour is not conveyed
during clinical encounters, or if the patient is feeling unwell,
he/she may stop taking them. The greater propensity to
experience side effects where a high number of medications
are taken is not always reported [18] and future studies
should include the consideration of side effects in polyphar-
macy, as this may help explain our findings. This may only be
one explanation, albeit an important one. Non-concordance
may also be related to the perceived burden of diabetes as
well as the number of medications and complexity of the
regimen [15,17].
Taking a higher number of cholesterol or diabetes medica-
tions was also significantly associated with non-concordance
at the univariate level but not in the multivariable analyses.
There is some research suggesting that non-concordance with
statins increases when overall number of medications is
increased, which again suggests that complexity of medica-
tion regimen is important [17]. Stack et al. [17] suggest that
individuals may value the importance of medications differ-
ently, prioritising diabetes medications over cholesterol-low-
ering ones. By contrast, an earlier study reported no consistent
difference in concordance with medications based on the type
of drugs (diabetes, cholesterol or blood pressure) being taken
[18].
Poorer clinic attendance as measured by failure to attend
appointments, a further indicator of poor self-care, was also
significantly associated with non-concordance, but this effect
did not persist in multivariable models. It is of concern that
patients appeared to remain disengaged with their healthcare
providers as evidenced by poor clinic attendance and what
seems to be an unwillingness to take their medications.
This may, in part, be related to communication difficulties
and poor knowledge of the importance of appropriate
Table 5 Logistic regression modelling: factors measured at baseline and at year 1 influencing non-concordance at year 2 follow-up
Variable Estimate P
Odds ratio
(95% CI)
Forward selection procedure (two models):
Model 1 – baseline factors + baseline concordance:
Non-concordant at baseline vs concordant 1.9473 < 0.0001 7.0 (2.7, 18.0)
EQ-5D self-care at baseline
Mild/Moderate/Severe vs None 1.0902 0.0016 3.0 (1.5, 5.9)
Number of blood pressure control medications prescribed at year 1 0.5127 < 0.0001 1.7 (1.3, 2.1)
Model 2 – baseline factors and concordance, plus concordance changes at year 1:
Non-concordant at baseline vs concordant 3.7955 < 0.0001 44.5 (11.0, 179.6)
Change from concordant at baseline to non-concordant at year 1 vs no change 2.7396 < 0.0001 15.5 (6.2, 38.8)
Change from non-concordant at baseline to concordant at year 1 vs no change 3.6344 0.0008 0.03 (0.003, 0.2)
EQ-5D self-care at baseline
Mild/Moderate /Severe vs None 1.0062 0.0131 2.7 (1.2, 6.1)
Number of blood pressure control medications prescribed at baseline 0.3482 0.0175 1.4 (1.1, 1.9)
Final Model – baseline factors and concordance, plus concordance changes at year 1 with adjustment for confounding:
Non-concordant at baseline vs concordant 3.6573 < 0.0001 38.8 (9.4, 159.1)
Change from concordant at baseline to non-concordant at year 1 vs no change 2.6058 < 0.0001 13.5 (5.2, 35.1)
Change from non-concordant at baseline to concordant at year 1 vs no change 3.4624 0.0024 0.03 (0.003, 0.3)
EQ-5D self-care at baseline
Mild/Moderate /Severe vs None 0.9218 0.0246 2.5 (1.1, 5.6)
Number of blood pressure control medications prescribed at baseline 0.3412 0.0213 1.4 (1.1, 1.9)
Duration of diabetes (years) 0.0238 0.4026 1.0 (1.0, 1.1)
HbA1c (Diabetes Control and Complications Trial-aligned) 0.0312 0.7532 1.0 (0.8, 1.3)
Sex (Male vs Female) 0.2962 0.4372 0.7 (0.4, 1.6)
Baseline family history of diabetes (Yes vs No) 0.1821 0.6314 1.2 (0.6, 2.5)
CI, Confidence Interval.
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medication-taking, both of which can be addressed in terms
of clinical practice.
The most important predictor of non-concordance at both
year 1 and 2 year follow-ups was prior concordance status,
with a role for number of blood pressure control medica-
tions. Furthermore, at year 2, change in concordance status
was a highly significant factor, further underlining the
importance of continued clinical care and encouraging
attendance at clinic appointments. Non-concordance with
medication-taking was also significantly associated with
poorer perceived health status, as measured by both
EQ-5D questionnaire and Visual Analogue Scale. This latter
scale is a useful one, especially in populations where there are
high levels of illiteracy, such as in the present study
population. In particular, those who reported severe anxiety
or depression on the EQ-5D also reported poorer concor-
dance with their medications, supporting previous studies
[19]. Poor mental health, and especially depression, has been
found to be much more common in people with diabetes [31]
and has been linked to poor health behaviours, including all
aspects of diabetes self-care (blood glucose monitoring,
medication taking, etc.) as well as poor attendance at
medical appointments [25]. Monitoring psychological well--
being is therefore of paramount importance, if positive
outcomes in terms of diabetes are to be achieved.
There are limitations to the present study. Our data on
prescribed medications relied on the transfer of information
from general practitioner medical records to UKADS case
notes and the medication list may not be exhaustive.
Self-reported concordance/non-concordance may be difficult
to measure accurately and it is possible that we may have
under- or overestimated non-concordance levels. Indeed, the
possibility of participants giving socially acceptable answers
regarding their medication-taking may have led to an
underestimation of the problem. Other studies have inves-
tigated the take up of prescriptions through an analysis of
pharmacy claims [15], but this is also problematic, as the
filling of a prescription does not guarantee that the
medication will be taken. It was possible to check study
participants’ reports of their prescribed medications using
the computerized medical records held for each patient, but
we have had to rely on self-report (and on participants
bringing their medications and repeat scripts to the consul-
tation) for actual level of medication-taking. We feel that
using Asian link workers to collect this information may
have assisted this process, however, as these workers were
able to develop a rapport with patients that was conducive
to an open and engaging consultation between the two
parties [32].
The present study, one of the first conducted in one
particular group of South-Asian patients, has highlighted the
need to address non-concordance with medications, a phe-
nomenon which we have found to be common in this
population with diabetes, and which persists over time.
Intensification of treatment is ineffective where there is
already poor concordance with prescribed medications and
alternative strategies for improving concordance with
treatment regimen need to be identified. Given the huge
economic cost of polypharmacy, alongside its importance in
delaying or preventing the development of diabetes com-
plications, this has important implications for both public
health and clinical practice. Alternative strategies for
increasing/improving diabetes self-management need to be
identified.
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